10-K Filing

HEALTHTECH SOLUTIONS, INC./UT CIK: 1307624 FY 2020

Filing Information

Form Type	10-K
Accession Number	`0001262463-21-000053`
Period End Date	20201231
Filing Date	20210302
Fiscal Year	2020
Fiscal Period	FY
XBRL Instance	hltt-20201231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 55 Income Statement 31 Cash Flow Statement 40 Stockholders Equity 12

Balance Sheet 55 line items

Line Item	Tag	Value	Unit	Period
Series A Preferred Stock,shares authorized	`PreferredStockSharesAuthorized`	2.00M	shares	Point-in-time
Series A Preferred Stock,shares authorized	`PreferredStockSharesAuthorized`	2.00M	shares	Point-in-time
Series A Preferred Stock, par value per share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Series A Preferred Stock, par value per share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$129.00K	USD	Point-in-time
Series A Preferred Stock, shares issued	`PreferredStockSharesIssued`	156,837.00	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Series A Preferred Stock, shares issued	`PreferredStockSharesIssued`	156,837.00	shares	Point-in-time
Series A Preferred Stock,shares outstanding	`PreferredStockSharesOutstanding`	156,837.00	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$10.00K	USD	Point-in-time
Series A Preferred Stock,shares outstanding	`PreferredStockSharesOutstanding`	156,837.00	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	-	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Due From related party	`DueFromRelatedPartiesCurrent`	$105.75K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Due From related party	`DueFromRelatedPartiesCurrent`	-	USD	Point-in-time
Common stock, par value per share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$139.00K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$105.75K	USD	Point-in-time
Common stock, par value per share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Intangible assets net of accumulated amortization	`FiniteLivedIntangibleAssetsNet`	$25.93K	USD	Point-in-time
Intangible assets net of accumulated amortization	`FiniteLivedIntangibleAssetsNet`	$64.81K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	9.70M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	9.70M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	9.70M	shares	Point-in-time
Total Assets	`Assets`	$170.57K	USD	Point-in-time
Total Assets	`Assets`	$164.92K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	9.70M	shares	Point-in-time
Convertible debentures payable, net of discount	`DebtInstrumentUnamortizedDiscountNoncurrent`	$325.82K	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	-	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	$3.79K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$36.40K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$80.17K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$36.40K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$83.96K	USD	Point-in-time
Convertible debentures payable, net of discount of $325,824	`ConvertibleDebtNoncurrent`	$305.68K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesNoncurrent`	$337.87K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesNoncurrent`	-	USD	Point-in-time
Total Long Term Liabilities	`LiabilitiesNoncurrent`	$643.56K	USD	Point-in-time
Total Long Term Liabilities	`LiabilitiesNoncurrent`	-	USD	Point-in-time
Total Liabilities	`Liabilities`	$36.40K	USD	Point-in-time
Total Liabilities	`Liabilities`	$727.52K	USD	Point-in-time
Series A preferred stock, $.001 par value, 2,000,000 authorized, 156,837 issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Series A preferred stock, $.001 par value, 2,000,000 authorized, 156,837 issued and outstanding	`PreferredStockValue`	$157.00	USD	Point-in-time
Common Stock, $0.001 par value, 200,000,000 shares authorized, 9,701,269 issued and outstanding	`CommonStockValue`	-	USD	Point-in-time
Common Stock, $0.001 par value, 200,000,000 shares authorized, 9,701,269 issued and outstanding	`CommonStockValue`	$9.70K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$866.25K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$840.67K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.44M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-706.50K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$308.84K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$134.17K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$-562.60K	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$164.92K	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$170.57K	USD	Point-in-time

Income Statement 31 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	-	USD	Annual
Revenue	`Revenues`	-	USD	Annual
General & administrative	`GeneralAndAdministrativeExpense`	$115.40K	USD	Annual
General & administrative	`GeneralAndAdministrativeExpense`	$71.10K	USD	Annual
General and administrative-related party	`OtherGeneralAndAdministrativeExpense`	$129.73K	USD	Annual
General and administrative-related party	`OtherGeneralAndAdministrativeExpense`	$119.14K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$206.44K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$348.77K	USD	Annual
Research and development related party	`ResearchAndDevelopmentRelatedParty`	$77.06K	USD	Annual
Research and development related party	`ResearchAndDevelopmentRelatedParty`	$113.10K	USD	Annual
Amortization	`AdjustmentForAmortization`	$38.89K	USD	Annual
Amortization	`AdjustmentForAmortization`	$38.89K	USD	Annual
Total Operating Expenses	`OperatingExpenses`	$709.86K	USD	Annual
Total Operating Expenses	`OperatingExpenses`	$548.67K	USD	Annual
Loss from Operations	`OperatingIncomeLoss`	$-548.67K	USD	Annual
Loss from Operations	`OperatingIncomeLoss`	$-709.86K	USD	Annual
Interest Expense	`InterestIncomeExpenseNet`	-	USD	Annual
Interest Expense	`InterestIncomeExpenseNet`	$-19.58K	USD	Annual
Change in fair value of derivative liabilities	`GainLossOnSaleOfDerivatives`	$-2.77K	USD	Annual
Change in fair value of derivative liabilities	`GainLossOnSaleOfDerivatives`	-	USD	Annual
Total Other Expenses	`NonoperatingIncomeExpense`	$-22.35K	USD	Annual
Total Other Expenses	`NonoperatingIncomeExpense`	-	USD	Annual
Net loss Before Provision for Income Tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$-548.67K	USD	Annual
Net loss Before Provision for Income Tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$-732.21K	USD	Annual
Provision for income tax	`IncomeTaxExpenseBenefit`	-	USD	Annual
Net Loss	`NetIncomeLoss`	$-548.67K	USD	Annual
Net Loss	`NetIncomeLoss`	$-732.21K	USD	Annual
Loss per common share, Basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	Annual
Loss per common share, Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.61	USD	Annual
Weighted average shares outstanding, Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	-	shares	Annual
Weighted average shares outstanding, Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	1.20M	shares	Annual

Cash Flow Statement 40 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-548.67K	USD	Annual
Net loss	`NetIncomeLoss`	$-732.21K	USD	Annual
Amortization expense	`AdjustmentForAmortization`	$38.89K	USD	Annual
Amortization expense	`AdjustmentForAmortization`	$38.89K	USD	Annual
Interest expense capitalized to convertible debentures payable	`PaidInKindInterest`	$6.51K	USD	Annual
Interest expense capitalized to convertible debentures payable	`PaidInKindInterest`	-	USD	Annual
Amortization of discount on convertible debentures	`AmortizationOfDebtDiscountPremium`	$9.28K	USD	Annual
Amortization of discount on convertible debentures	`AmortizationOfDebtDiscountPremium`	-	USD	Annual
Fair value change in derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	-	USD	Annual
Fair value change in derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$2.77K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$10.00K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	-	USD	Annual
Due From related party	`IncreaseDecreaseInDueFromRelatedParties`	$-105.75K	USD	Annual
Due From related party	`IncreaseDecreaseInDueFromRelatedParties`	$-115.38K	USD	Annual
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	-	USD	Annual
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$3.79K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$43.77K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$20.40K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-531.45K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-374.00K	USD	Annual
Cash paid upon reverse merger	`RepaymentsOfOtherShortTermDebt`	$235.00K	USD	Annual
Cash paid upon reverse merger	`RepaymentsOfOtherShortTermDebt`	-	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-235.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	Annual
Proceeds from convertible debentures	`ProceedsFromConvertibleDebt`	-	USD	Annual
Proceeds from convertible debentures	`ProceedsFromConvertibleDebt`	$625.00K	USD	Annual
Capital contributions	`ProceedsFromContributionsFromParent`	$374.00K	USD	Annual
Capital contributions	`ProceedsFromContributionsFromParent`	$270.44K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$374.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$895.44K	USD	Annual
Net change in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$129.00K	USD	Annual
Net change in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	-	USD	Annual
Cash, cash equivalents, and restricted cash beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$129.00K	USD	Point-in-time
Cash, cash equivalents, and restricted cash beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Cash, cash equivalents, and restricted cash end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$129.00K	USD	Point-in-time
Cash, cash equivalents, and restricted cash end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	-	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	-	USD	Annual
Cash paid for interest	`InterestPaidNet`	-	USD	Annual
Cash paid for taxes	`IncomeTaxesPaid`	-	USD	Annual
Cash paid for taxes	`IncomeTaxesPaid`	-	USD	Annual

Stockholders Equity 12 line items

Line Item	Tag	Value	Unit	Period
Balance, value	`StockholdersEquity`	$308.84K	USD	Point-in-time
Balance, value	`StockholdersEquity`	$134.17K	USD	Point-in-time
Balance, value	`StockholdersEquity`	$-562.60K	USD	Point-in-time
Capital contributions	`AdjustmentsToAdditionalPaidInCapitalOther`	$270.44K	USD	Annual
Capital contributions	`AdjustmentsToAdditionalPaidInCapitalOther`	$374.00K	USD	Annual
Effect of reverse merger transaction, value	`StockIssuedDuringPeriodValueOther`	-	USD	Annual
Effect of reverse merger transaction, value	`StockIssuedDuringPeriodValueOther`	$-235.00K	USD	Annual
Net Loss	`NetIncomeLoss`	$-548.67K	USD	Annual
Net Loss	`NetIncomeLoss`	$-732.21K	USD	Annual
Balance, value	`StockholdersEquity`	$308.84K	USD	Point-in-time
Balance, value	`StockholdersEquity`	$134.17K	USD	Point-in-time
Balance, value	`StockholdersEquity`	$-562.60K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.